Banner - Collaborative Care Symposium

News
Media
Conferences
Blog
Publications
Partners
Resources
Subscribe
CE

Navneet Puri, PhD

Articles by Navneet Puri, PhD

Pipeline: Presbyopia, night vision disturbance up next for Vyluma

ByNavneet Puri, PhD,Gretchyn M. Bailey, NCLC, FAAO, Editor in Chief, Content Channel Director,Brooke Henson, Editor

July 24th 2021

First Vyluma product tackles pediatric myopia

ByNavneet Puri, PhD,Gretchyn M. Bailey, NCLC, FAAO, Editor in Chief, Content Channel Director,Brooke Henson, Editor

July 23rd 2021

Vyluma pipeline focuses on refractive error

ByNavneet Puri, PhD,Gretchyn M. Bailey, NCLC, FAAO, Editor in Chief, Content Channel Director,Brooke Henson, Editor

July 22nd 2021

Nevakar spins off ophthalmic-only company Vyluma

ByGretchyn M. Bailey, NCLC, FAAO, Editor in Chief, Content Channel Director,Navneet Puri, PhD,Brooke Henson, Editor

June 1st 2021

A new ophthalmic-only pharma company was formed when Nevakar spun off its pipeline of ocular drugs.

Latest Updated Articles

Pipeline: Presbyopia, night vision disturbance up next for Vyluma
Published: July 24th 2021 | Updated:
First Vyluma product tackles pediatric myopia
Published: July 23rd 2021 | Updated:
Nevakar spins off ophthalmic-only company Vyluma
Published: June 1st 2021 | Updated:
$Vyluma pipeline focuses on refractive error$
Vyluma pipeline focuses on refractive error
Published: July 22nd 2021 | Updated:

Trending on Optometry Times - Clinical News & Expert Optometrist Insights

Focus on 2026: What’s trending for optometry in the coming year

A new treatment round-up for AMD and GA

Breaking news: FDA sends CRL to Outlook Therapeutics for ONS-5010 resubmission

Dry eye and macular degeneration: A convergence of aging, inflammation, and telomere biology

Crafting your own eyewear brand: Advice for getting started